Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine Augmentation of Fluoxetine in TS-Spectrum OCD
NCT00000373Phase 4Completed
- Sponsor
- University of Florida
- Start
- Sep 1992
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olanzapine in obsessive compulsive disorder (OCD), sponsored by University of Florida. Started Sep 1992; status: completed.
02
Drugs
olanzapine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00000373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000373.